Skip to main content

Market Overview

What's Happening With ACER Stock, MGM Stock, XPEV Stock?

Share:
What's Happening With ACER Stock, MGM Stock, XPEV Stock?

One of the most common questions traders have about stocks is “Why Is It Moving?”

That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.

Here’s the price action and updates for Acer Therapeutics, MGM and Xpeng Monday morning.

Acer Therapeutics Inc (NASDAQ: ACER) shares were soaring 67.74% premarket Monday to $5.72. 

It's rumored that Acer may merge with RELIEF THERAPEUTICS Holding SA (Pink: RLFTF).

Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need.

Jefferies analyst David Katz upgraded MGM Resorts International (NYSE: MGM) Monday from Hold to Buy and raised the price target from $36 to $50.

Shares of MGM were trading higher by 2.49% at $39.95 at last check. 

Xpeng Inc - ADR (NYSE: XPEV) shares were trading higher by 1.96% at $35.84 after the company received $78 million of funding from a Chinese provincial government.

 

Related Articles (MGM + ACER)

View Comments and Join the Discussion!

Posted-In: Analyst Color News Penny Stocks Upgrades Price Target Small Cap Analyst Ratings Best of Benzinga

Latest Ratings

StockFirmActionPT
PHXSeaport GlobalInitiates Coverage On
AFCGLake StreetInitiates Coverage On29.0
OSSNoble Capital MarketsUpgrades7.0
NCNOGabelli & Co.Upgrades
HAECJS SecuritiesUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com